Deutsche Bank’s Medicines Co MDCO Stock Holding History

Deutsche Bank’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-1,479	Closed	-$1K	–	5825
2013 Q2	$1K	Buy	+1,479	New	+$49.5K	﹤0.01%	5314

Other funds holding MDCO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Deutsche Bank's MDCO Position: Q1 2020 in Review

Deutsche Bank sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 44,804 shares — an estimated $3.8M sold.

Deutsche Bank first reported a position in MDCO in Q2 2013 and held it in 27 quarters. The position peaked at $36.6M in Q3 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

Deutsche Bank reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
Deutsche Bank sold 44,804 Medicines Co shares in Q1 2020, an estimated $3.8M.
Deutsche Bank first reported a position in Medicines Co in Q2 2013 and held it in 27 quarters.
Deutsche Bank's Medicines Co position peaked at $36.6M in Q3 2019.
1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Deutsche Bank's 13F filing for Q1 2020, filed 14 May 2020.